...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zhlcf

I am temptedĀ  but it looks to good to be true.However I had 20k shares and now have 100 more.My original are from the spinoff.These market makers are either nuts or we are.

Share
New Message
Please login to post a reply